Skip to main content

Boston Scientific Corp

BSX
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000885725

In the last 90 days, Boston Scientific Corp insiders filed 5 open-market purchases and 0 sales; 1,485 institutions reported holding it in 13F filings for Q2 2026, worth $57.3B in total; Maverick Capital is the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Boston Scientific Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
5 filings
4 insiders, $9.49M in total
Open-market sells
0 filings
Insiders trading
4
Net value
+$9.49M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Boston Scientific Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Boston Scientific Corp
NameTitleLast reported holdingLast filingFilings, past year
O'Connor Padraig AndrewEVP, Global Operations7,892Sep 3, 20264
Morano Susan EDirector13,784Aug 26, 20263
Woodworth EmilySVP, Global Controller and CAO2,930IndirectAug 12, 20264
Monson JonathanEVP and CFO9,908IndirectAug 11, 20264
Habiger David CDirector17,160Aug 7, 20264
Mahoney Michael FChairman, President & CEO22,119IndirectAug 5, 20266
Ludwig Edward JDirector30,359Aug 3, 20263
Fitzgerald Joseph MichaelEVP & Group Pres, Cardiology64,198IndirectAug 3, 20266
Pegus CherylDirector1,770May 21, 20263
Wichmann David SDirector45,382May 11, 20261
Smith Cathy RDirector–May 11, 20262
Zane Ellen MDirector27,934May 11, 20264
Mega Jessica LDirector12,035May 11, 20261
Weber Christophe PierreDirector3,786May 11, 20262
Butcher Arthur CEVP& Grp Pres, MedSurg & APAC56,887May 4, 20265
Brown Vance REVP, GC and Corp. Secretary54,244Feb 18, 20262
O'Sullivan MiriamSVP, Chief HR Officer17,302Feb 18, 20263
Fujimori YoshiakiDirector2,081Jul 30, 20250
Sununu John EDirector54,723May 9, 20250
Sorenson John BradleyEVP, Global Operations18,705May 6, 20250
Mirviss Jeffrey B.EVP&Pres, Periph Intervent25,766Feb 25, 20250
Brennan Daniel J.EVP and CFO225,808Feb 19, 20250
Carruthers WendyEVP, Human Resources29,308Dec 4, 20240
Dockendorff Charles JDirector2,901May 13, 20240
Thepaut Eric Francis YvesEVP & Pres, Eur, Mid-East, Afr31,422May 13, 20240
Roux David JDirector73,591May 5, 20230
Connors Nelda JDirector8,823May 5, 20230
James DonnaDirector–May 6, 20220
Scanlon MeghanSVP,Pres,Urology Pelvic Health24,461May 2, 20220
Eddy Jodi EuerleSVP, Chief Info & Digital Off.23,263Apr 4, 20220
Olson ScottSVP & Pres, CRM, Diagnostics14,518Apr 1, 20220
Meredith Ian TEVP Global Chief Med Officer28,082Mar 29, 20220
Nanavaty MaulikSVP & Pres, Neuromodulation177,258Mar 2, 20220
Pierce David AEVP Pres MedSurg0Mar 2, 20220
Mackey Edward FEVP, Operations52,944Mar 2, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 9, 2022 (view filing)Aug 81 dayMahoney Michael FChairman, President & CEOSSale−125.8K$40.97−$5.16M−5.6%2.13M after
Aug 15, 2022 (view filing)Aug 15Same dayCarruthers WendyEVP, Human ResourcesSSale−7.50K$42.03−$315.2K−6.0%117.4K after
Sep 7, 2022 (view filing)Sep 61 dayMahoney Michael FChairman, President & CEOSSale−125.8K$40.49−$5.09M−6.6%1.77M after
Sep 16, 2022 (view filing)Sep 151 dayCarruthers WendyEVP, Human ResourcesSSale−7.50K$42.21−$316.6K−6.4%109.9K after
Oct 4, 2022 (view filing)Oct 31 dayMahoney Michael FChairman, President & CEOSSale−125.8K$39.34−$4.95M−6.6%1.77M after
Oct 18, 2022 (view filing)Oct 171 dayCarruthers WendyEVP, Human ResourcesSSale−13.3K$40.52−$539.8K−12.1%96.6K after
Nov 8, 2022 (view filing)Nov 71 dayMahoney Michael FChairman, President & CEOSSale−125.8K$41.97−$5.28M−6.6%1.77M after
Nov 15, 2022 (view filing)Nov 15Same dayCarruthers WendyEVP, Human ResourcesSSale−1.68K$42.60−$71.5K−1.7%94.9K after
Nov 21, 2022 (view filing)Nov 183 daysThepaut Eric Francis YvesEVP & Pres, Eur, Mid-East, AfrSSale−15.0K$42.72−$638.7K−20.6%57.5K after
Nov 30, 2022 (view filing)Nov 291 dayConnors Nelda JDirectorSSale−18.2K$44.47−$809.2K−40.0%27.2K after
Dec 12, 2022 (view filing)Dec 93 daysMirviss Jeffrey B.EVP&Pres, Periph InterventSSale−41.0K$46.15−$1.89M−29.2%99.6K after
Dec 13, 2022 (view filing)Dec 121 dayMirviss Jeffrey B.EVP&Pres, Periph InterventSSale−11.1K$46.75−$518.0K−11.1%88.5K after
Dec 14, 2022 (view filing)Dec 131 dayFitzgerald Joseph MichaelEVP & Group Pres, CardiologySSale−79.3K$47.78−$3.79M−26.8%216.9K after
Dec 15, 2022 (view filing)Dec 15Same dayCarruthers WendyEVP, Human ResourcesSSale−7.50K$46.62−$349.6K−7.9%87.4K after
Jan 4, 2023 (view filing)Jan 4Same dayMirviss Jeffrey B.EVP&Pres, Periph InterventSSale−6.75K$46.38−$313.1K−7.1%88.5K after
Feb 6, 2023 (view filing)Feb 33 daysButcher Arthur CEVP& Grp Pres, MedSurg & APACSSale−27.0K$48.74−$1.32M−53.6%23.4K after
Feb 16, 2023 (view filing)Feb 151 dayBrennan Daniel J.EVP and CFOSSale−7.57K$47.14−$356.9K−2.7%276.3K after
Feb 21, 2023 (view filing)Feb 16-175 daysMirviss Jeffrey B.EVP&Pres, Periph InterventSSale−3.47K$46.53−$161.5K−3.7%90.8K after2 lots
Feb 22, 2023 (view filing)Feb 21-221 dayMirviss Jeffrey B.EVP&Pres, Periph InterventSSale−5.65K$46.19−$261.1K−6.0%88.5K after2 lots
Mar 2, 2023 (view filing)Mar 11 dayMonson JonathanSVP, Global Controller and CAOSSale−5.00K$46.66−$233.3K−12.5%34.9K after
Mar 2, 2023 (view filing)Mar 1-21 dayBrennan Daniel J.EVP and CFOSSale−105.6K$46.65−$4.93M−31.9%226.0K after2 lots
Mar 16, 2023 (view filing)Mar 151 dayCarruthers WendyEVP, Human ResourcesSSale−11.7K$47.60−$555.5K−11.6%88.6K after
Mar 24, 2023 (view filing)Mar 231 dayButcher Arthur CEVP& Grp Pres, MedSurg & APACSSale−6.70K$47.97−$321.5K−22.6%23.0K after
Mar 31, 2023 (view filing)Mar 301 dayMirviss Jeffrey B.EVP&Pres, Periph InterventSSale−4.90K$49.60−$243.2K−5.5%83.6K after
Mar 31, 2023 (view filing)Mar 31Same dayMonson JonathanSVP, Global Controller and CAOSSale−5.00K$50.00−$250.0K−12.5%34.9K after
Mar 31, 2023 (view filing)Mar 31Same daySorenson John BradleyEVP, Global OperationsSSale−4.00K$50.00−$200.0K−10.4%34.4K after
Apr 6, 2023 (view filing)Apr 51 dayMirviss Jeffrey B.EVP&Pres, Periph InterventSSale−4.90K$50.40−$247.1K−5.9%78.7K after
Apr 18, 2023 (view filing)Apr 171 dayCarruthers WendyEVP, Human ResourcesSSale−11.7K$51.96−$606.4K−12.3%83.4K after
May 3, 2023 (view filing)May 21 dayThepaut Eric Francis YvesEVP & Pres, Eur, Mid-East, AfrSSale−83.4K$52.49−$4.38M−87.2%12.3K after
May 17, 2023 (view filing)May 152 daysCarruthers WendyEVP, Human ResourcesSSale−11.7K$53.49−$624.3K−13.0%78.1K after
May 17, 2023 (view filing)May 161 dayFitzgerald Joseph MichaelEVP & Group Pres, CardiologySSale−63.3K$53.60−$3.39M−22.8%213.9K after
Jun 15, 2023 (view filing)Jun 15Same dayCarruthers WendyEVP, Human ResourcesSSale−11.7K$53.24−$621.4K−13.8%72.8K after
Jun 22, 2023 (view filing)Jun 211 dayButcher Arthur CEVP& Grp Pres, MedSurg & APACSSale−6.70K$53.80−$360.3K−27.7%17.5K after
Jul 18, 2023 (view filing)Jul 171 dayCarruthers WendyEVP, Human ResourcesSSale−11.7K$52.85−$616.8K−14.7%67.6K after
Aug 15, 2023 (view filing)Aug 15Same dayCarruthers WendyEVP, Human ResourcesSSale−11.7K$51.30−$598.7K−15.8%62.3K after
Aug 18, 2023 (view filing)Aug 18Same dayDockendorff Charles JDirectorSSale−17.1K$50.74−$866.6K−81.2%3.95K after10b5-1
Aug 22, 2023 (view filing)Aug 211 dayButcher Arthur CEVP& Grp Pres, MedSurg & APACSSale−6.60K$50.40−$332.6K−36.7%11.4K after
Aug 28, 2023 (view filing)Aug 253 daysBrown Vance RSVP, GC and Corp. SecretarySSale−15.8K$50.52−$795.7K−35.5%28.6K after10b5-1
Aug 30, 2023 (view filing)Aug 28-292 daysMirviss Jeffrey B.EVP&Pres, Periph InterventSSale−18.6K$53.48−$996.2K−23.5%60.6K after2 lots10b5-1
Sep 12, 2023 (view filing)Sep 12Same dayMahoney Michael FChairman, President & CEOSSale−113.4K$53.91−$6.11M−7.0%1.50M after
Sep 15, 2023 (view filing)Sep 15Same dayCarruthers WendyEVP, Human ResourcesSSale−11.7K$53.95−$629.7K−17.0%57.1K after
Sep 21, 2023 (view filing)Sep 201 dayFitzgerald Joseph MichaelEVP & Group Pres, CardiologySSale−15.9K$55.00−$872.7K−7.4%198.0K after
Oct 10, 2023 (view filing)Oct 91 dayMahoney Michael FChairman, President & CEOSSale−113.4K$52.09−$5.90M−7.0%1.50M after
Oct 17, 2023 (view filing)Oct 161 dayCarruthers WendyEVP, Human ResourcesSSale−11.7K$49.79−$581.1K−18.4%51.8K after
Nov 7, 2023 (view filing)Nov 61 dayMahoney Michael FChairman, President & CEOSSale−113.4K$52.51−$5.95M−7.0%1.50M after
Nov 16, 2023 (view filing)Nov 151 dayCarruthers WendyEVP, Human ResourcesSSale−11.7K$54.17−$632.2K−20.1%46.5K after
Nov 21, 2023 (view filing)Nov 201 dayButcher Arthur CEVP& Grp Pres, MedSurg & APACSSale−8.28K$54.06−$447.5K−54.3%6.98K after
Dec 7, 2023 (view filing)Dec 61 dayMirviss Jeffrey B.EVP&Pres, Periph InterventSSale−353$55.03−$19.4K−0.6%56.6K after10b5-1
Dec 18, 2023 (view filing)Dec 153 daysCarruthers WendyEVP, Human ResourcesSSale−11.7K$55.61−$649.1K−22.0%41.3K after
Jan 2, 2024 (view filing)Dec 29, 20234 daysFitzgerald Joseph MichaelEVP & Group Pres, CardiologySSale−81.9K$57.50−$4.71M−32.0%174.2K after